|
GB8709871D0
(en)
*
|
1987-04-27 |
1987-06-03 |
Turner R C |
Peptides
|
|
AU634716B2
(en)
|
1988-08-01 |
1993-03-04 |
Ciba Corning Diagnostics Corp. |
Method for detection of an analyte using acridinium esters and liposomes
|
|
US5430047A
(en)
*
|
1994-04-07 |
1995-07-04 |
Warner-Lambert Company |
Neurotensin antagonists
|
|
EP0803255A4
(en)
*
|
1994-06-03 |
1999-06-30 |
Tsumura & Co |
DRUG
|
|
WO1999046283A1
(en)
*
|
1998-03-09 |
1999-09-16 |
Zealand Pharmaceuticals A/S |
Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
|
|
US6248527B1
(en)
*
|
1998-10-21 |
2001-06-19 |
Millennium Pharmaceuticals, Inc. |
Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E
|
|
US6818418B1
(en)
|
1998-12-10 |
2004-11-16 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
|
IL142707A0
(en)
*
|
2000-04-27 |
2002-03-10 |
Pfizer Prod Inc |
Methods of treating obesity using a neurotensin receptor ligand
|
|
US7271153B2
(en)
*
|
2001-06-20 |
2007-09-18 |
Kissei Pharmaceutical Co., Ltd. |
Nitrogenous heterocyclic derivatives, medicinal compositions containing the same, medicinal uses thereof, and intermediates therefor
|
|
IL160289A0
(en)
|
2001-08-30 |
2004-07-25 |
Biorexis Pharmaceutical Corp |
Modified transferrin fusion proteins
|
|
EP2298278B1
(en)
|
2002-06-07 |
2015-11-11 |
Dyax Corp. |
Prevention and reduction of blood loss and inflammatory response
|
|
US20050164301A1
(en)
|
2003-10-24 |
2005-07-28 |
Avidia Research Institute |
LDL receptor class A and EGF domain monomers and multimers
|
|
US20100028995A1
(en)
|
2004-02-23 |
2010-02-04 |
Anaphore, Inc. |
Tetranectin Trimerizing Polypeptides
|
|
AU2005287557B2
(en)
|
2004-09-21 |
2011-10-13 |
Biontech Ag |
Use of microproteins as tryptase inhibitors
|
|
DE102005003687A1
(de)
*
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
|
JP2008538812A
(ja)
*
|
2005-04-11 |
2008-11-06 |
アストラゼネカ アクチボラグ |
方法
|
|
US8119358B2
(en)
*
|
2005-10-11 |
2012-02-21 |
Tethys Bioscience, Inc. |
Diabetes-related biomarkers and methods of use thereof
|
|
ATE527353T1
(de)
|
2007-12-19 |
2011-10-15 |
Affibody Ab |
Pdgf-bindendes polypeptid aus protein a
|
|
NZ592591A
(en)
|
2008-11-03 |
2012-04-27 |
Molecular Partners Ag |
Binding proteins comprising ankyrin repeast domains that inhibit the vegf-a receptor interaction
|
|
AU2009322043A1
(en)
*
|
2008-12-05 |
2011-07-07 |
Angiochem Inc. |
Conjugates of neurotensin or neurotensin analogs and uses thereof
|
|
US8586043B2
(en)
|
2009-01-07 |
2013-11-19 |
Inserm ( Institut National De La Sante Et De La Recherche Medicale) |
Methods for treating breast cancer with inhibitors of neurotensin activation of NTSR1
|
|
BR112012004314A2
(pt)
|
2009-08-27 |
2016-11-29 |
Covagen Ag |
compostos de ligação a il-17 e usos medicinais desses compostos
|
|
EP2494364A1
(en)
*
|
2009-10-29 |
2012-09-05 |
Tethys Bioscience, Inc. |
Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes
|
|
CA2778871C
(en)
|
2009-12-14 |
2017-08-01 |
Scil Proteins Gmbh |
Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin
|
|
UA58612U
(uk)
*
|
2010-06-04 |
2011-04-26 |
Высшее Государственное Учебное Заведение «Украинская Медицинская Стоматологическая Академия» |
Спосіб діагностики інсулінорезистентності у хворих на метаболічний синдром та цукровий діабет 2 типу
|
|
WO2011154420A2
(en)
|
2010-06-08 |
2011-12-15 |
Pieris Ag |
Tear lipocalin muteins binding il-4 r alpha
|
|
CA2977494A1
(en)
*
|
2015-02-27 |
2016-05-06 |
Sphingotec Gmbh |
A method for predicting the risk of obesity in a subject
|